 |
The Alliance for Aging Research is a non-profit organization based in Washington, D.C., that promotes medical research to improve the human experience of aging. [1] Founded in 1986 by Daniel Perry, the Alliance also advocates and implements health education for consumers and health professionals.
The Alliance is governed by a board of directors. Susan Peschin is the chief executive officer and president.
Main policy areas include aging research funding, FDA funding, stem cell research funding and improving health care for older Americans. The Alliance holds congressional briefings to increase awareness of such diseases and conditions as osteoporosis, Alzheimer's disease, oral care and diabetes.
The Alliance also serves on a number of coalitions and committees including: Friends of the National Institute on Aging (NIA), [2] the Alliance for a Stronger FDA, [3] Coalition for the Advancement of Medical Research (CAMR), [4] Partnership to Fight Chronic Disease, [5] and the National Coalition on Mental Health and Aging. [6]
The Alliance has been a part of the once-a-decade White House Conference on Aging, helping the President and Congress adopt resolutions to make aging research a national priority. [7]
The Alliance collaborates with many patient and advocacy organizations on the annual Task Force on Aging Research Funding, a call to action to Congress and other national policymakers. [8]
ACT-AD (Accelerate Cure/ Treatments for Alzheimer's Disease) is a coalition of more than 50 organizations working to accelerate the development of treatments and a cure for Alzheimer's disease. [9]
The Alliance produces materials focused on healthy aging and chronic disease, particularly for the Baby Boomer population. The Alliance has developed resources on the following topics: Age-related macular degeneration, Alzheimer's disease and caregivers, osteoporosis, heart disease, Parkinson's disease and cancer, among others.
The Baby Boomer population now includes about 78 million Americans—27 million are ages 55–62 and 51 million ages 44–54. [10] This generation will begin reaching age 65 in 2011—increasing the need for healthy aging and chronic disease research. [11]
The Alliance has also developed a database called The Silver Book that compiles facts, statistics, graphs and data from hundreds of sources. A brief version of the online database is available in print form. Data is available for diabetes, vision loss, neurological diseases, cardiovascular disease, cancer, and osteoporosis.
Every year the Alliance holds its Bipartisan Congressional Awards Dinner to highlight how policymakers work together to advance aging research and celebrate recent achievements. [12]
In 2008, the Alliance presented the Florence S. Mahoney Making A Difference Award, which honors an individual for his or her contribution to the medical research community, to Erik Fatemi. [13] The award remembers Florence S. Mahoney, who was instrumental in the foundation of the National Institute on Aging. [14]
From 2002-2008, the Alliance has hosted "Aged to Perfection", a wine tasting fundraiser bringing together individuals and experts from the biotechnology, health, finance, political and wine communities in order to show support for aging research. [15]
The Alliance received two grants from Pfizer in 2021 for a total of $120,000, the majority of which went towards a "COVID-19 Vaccine Education and Equity Project". [16]
Stanozolol, sold under many brand names, is an androgen and anabolic steroid (AAS) medication derived from dihydrotestosterone (DHT). It is used to treat hereditary angioedema. It was developed by American pharmaceutical company Winthrop Laboratories in 1962, and has been approved by the U.S. Food and Drug Administration for human use, though it is no longer marketed in the USA. It is also used in veterinary medicine. Stanozolol has mostly been discontinued, and remains available in only a few countries. It is given by mouth in humans or by injection into muscle in animals.
The National Institute on Aging (NIA) is a division of the U.S. National Institutes of Health (NIH), located in Bethesda, Maryland. The NIA itself is headquartered in Baltimore, Maryland.
Proposition 71 of 2004 is a law enacted by California voters to support stem cell research in the state. It was proposed by means of the initiative process and approved in the 2004 state elections on November 2. The Act amended both the Constitution of California and the Health and Safety Code.
The Alzheimer's Association was founded by Jerome H. Stone with the help of several family members in Chicago, Illinois. Incorporated on April 10, 1980, as the Alzheimer's Disease and Related Disorders Association, Inc., it is a non-profit American volunteer health organization which focuses on care, support and research for Alzheimer's disease.
Pneumococcal vaccines are vaccines against the bacterium Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis. There are two types of pneumococcal vaccines: conjugate vaccines and polysaccharide vaccines. They are given by injection either into a muscle or just under the skin.
The Arthritis Foundation is a nonprofit organization that is dedicated to addressing the needs of people living with arthritis in the United States. There are nearly 60 million adults and 300,000 children living with arthritis, the nation's leading cause of disability. The Foundation works to provide information and resources, access to care, advancements in science and community connections.
An aging-associated disease is a disease that is most often seen with increasing frequency with increasing senescence. They are essentially complications of senescence, distinguished from the aging process itself because all adult animals age but not all adult animals experience all age-associated diseases. The term does not refer to age-specific diseases, such as the childhood diseases chicken pox and measles, only diseases of the elderly. They are also not accelerated aging diseases, all of which are genetic disorders.
John Quinn Trojanowski was an American academic research neuroscientist specializing in neurodegeneration. He and his partner, Virginia Man-Yee Lee, MBA, Ph.D., are noted for identifying the roles of three proteins in neurodegenerative diseases: tau in Alzheimer's disease, alpha-synuclein in Parkinson's disease, and TDP-43 in Amyotrophic Lateral Sclerosis (ALS) and frontotemporal degeneration.
The National Health Council (NHC) is a nonprofit association of health organizations.
The National Organization for Rare Disorders (NORD) is an American non-profit organization aiming to provide support for individuals with rare diseases by advocating and funding research, education, and networking among service providers. It was founded in 1983 by Abbey Meyers, along with individuals and rare diseases leaders of rare disease support groups, and it is a 501(c)3 tax exempt organization.
The Redstone Acceleration & Innovation Network (TRAIN) is an organization launched by FasterCures in 2004 established to create opportunities for medical research organizations to discuss and overcome research challenges that cut across all diseases. TRAIN brings together nonprofit disease research organizations to share information, as well as promote collaboration and innovation in disease research. Headed by FasterCures, TRAIN asserts that collaboration is crucial for efficient biomedical advancement. Participating researchers discuss successes, failures, and best practices that provide lessons learned and valuable ideas that could be scaled up to amplify productivity.
Samuel E. Gandy, is a neurologist, cell biologist, Alzheimer's disease (AD) researcher and expert in the metabolism of the sticky substance called amyloid that clogs the brain in patients with Alzheimer's. His team discovered the first drugs that could lower the formation of amyloid.
Critical Path Institute (C-Path) is a non-profit organization created to improve the drug development process; its consortia include more than 1,600 scientists from government regulatory and research agencies, academia, patient organizations, and bio-pharmaceutical companies.
The Alzheimer's Foundation of America (AFA) is an American nonprofit organization based in New York City whose mission is to provide support, services and education to individuals, families and caregivers affected by Alzheimer's disease and related dementias nationwide, and fund research for better treatment and a cure. AFA unites more than 2,000 member organizations from coast-to-coast that are dedicated to meeting the educational, social, emotional and practical needs of individuals with Alzheimer's disease and related illnesses, and their caregivers and families. Member organizations include grassroots Alzheimer's agencies, senior centers, adult daycare center, home healthcare agencies, long-term care residences, research facilities, and other dementia-related groups. AFA holds Charity Navigator's highest rating of 4 stars.
The Foundation for the National Institutes of Health (FNIH) is a not-for-profit, 501(c)(3) charitable organization established by the US Congress in 1990. Located in North Bethesda, MD, the FNIH raises private-sector funds, and creates and manages alliances with public and private institutions in support of the mission of the National Institutes of Health (NIH).
Vivian Winona Pinn is an American physician-scientist and pathologist known for her advocacy of women's health issues and concerns, particularly for ensuring that federally funded medical studies include female patients, and well as encouraging women to follow medical and scientific careers. She served as associate director for research on women's health at the National Institutes of Health (NIH), concurrently was the inaugural director of NIH's Office of Research on Women's Health. Pinn previously taught at Harvard University, Tufts University, and Howard University College of Medicine. Since retiring from NIH in 2011, Pinn has continued working as a senior scientist emerita at the Fogarty International Center.
The 21st Century Cures Act is a United States law enacted by the 114th United States Congress in December 2016 and then signed into law on December 13, 2016. It authorized $6.3 billion in funding, mostly for the National Institutes of Health. The act was supported especially by large pharmaceutical manufacturers and was opposed especially by some consumer organizations.
The Alliance for Biosecurity is a consortium of companies that develop products to respond to national security threats, including bioterrorism pathogens and emerging infectious diseases. It is headquartered in Washington DC.
SARS-CoV-2, the virus that causes COVID-19, was isolated in late 2019. Its genetic sequence was published on 11 January 2020, triggering the urgent international response to prepare for an outbreak and hasten development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration in the multinational pharmaceutical industry and between governments. By June 2020, tens of billions of dollars were invested by corporations, governments, international health organizations, and university research groups to develop dozens of vaccine candidates and prepare for global vaccination programs to immunize against COVID‑19 infection. According to the Coalition for Epidemic Preparedness Innovations (CEPI), the geographic distribution of COVID‑19 vaccine development shows North American entities to have about 40% of the activity, compared to 30% in Asia and Australia, 26% in Europe, and a few projects in South America and Africa.
